We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss.
Find out about the long-term effects some people can have after having COVID-19.
This study aims to identify the reasons for not undergoing confirmation by those at high risk for developing diabetes
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
How to use a cost effectiveness analysis to evaluate your digital health product.
A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital
This case study analyses a peer educator diabetes programme, MoPoTsyo, from a health system’s perspective
Further information on what drivers with different types of diabetes need to tell DVLA by law.
Analysis of risk factors for pre-diabetes (also called non-diabetic hyperglycaemia, or NDH) and undiagnosed type 2 diabetes among adults.
Information to support your recovery after COVID-19.
How to use a quasi-experimental study to evaluate your digital health product.
Guidance on listed diseases of fish and shellfish and their status in England and Wales, including what happens if a disease is suspected or confirmed.
Using an ecological momentary assessment to evaluate your digital health product.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
The VIA tool shows how inpatient activity for patients with diabetes differs from a similar patient population without diabetes.
Overview of the UK's diabetes research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Sets out the government's quality standards for diabetes services.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.